P.Y. Dietrich

650 total citations
17 papers, 452 citations indexed

About

P.Y. Dietrich is a scholar working on Immunology, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, P.Y. Dietrich has authored 17 papers receiving a total of 452 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 5 papers in Pathology and Forensic Medicine and 5 papers in Oncology. Recurrent topics in P.Y. Dietrich's work include Immunotherapy and Immune Responses (6 papers), Lymphoma Diagnosis and Treatment (4 papers) and Cancer Immunotherapy and Biomarkers (3 papers). P.Y. Dietrich is often cited by papers focused on Immunotherapy and Immune Responses (6 papers), Lymphoma Diagnosis and Treatment (4 papers) and Cancer Immunotherapy and Biomarkers (3 papers). P.Y. Dietrich collaborates with scholars based in Switzerland, France and Italy. P.Y. Dietrich's co-authors include Sandro Anchisi, France M. Laurencet, Matti Aapro, Pedro Romero, Anne Caignard, Jos Even, Apiradee Lim, Nicolas de Tribolet, Thierry Hercend and Frédéric Triebel and has published in prestigious journals such as Journal of Clinical Oncology, The EMBO Journal and Cancer Research.

In The Last Decade

P.Y. Dietrich

15 papers receiving 424 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
P.Y. Dietrich Switzerland	12	185	150	114	108	101	17	452
Vanessa Szablewski France	16	232 1.3×	113 0.8×	94 0.8×	304 2.8×	78 0.8×	46	577
Lisa Lassay Germany	9	174 0.9×	117 0.8×	53 0.5×	116 1.1×	55 0.5×	21	535
Shelley A. Roberts United States	10	215 1.2×	69 0.5×	135 1.2×	159 1.5×	19 0.2×	13	479
Lauris Gastaud France	12	191 1.0×	74 0.5×	65 0.6×	110 1.0×	70 0.7×	36	395
T Philip France	14	265 1.4×	97 0.6×	165 1.4×	167 1.5×	76 0.8×	46	692
Yohei Yamamoto Japan	13	87 0.5×	109 0.7×	160 1.4×	25 0.2×	86 0.9×	25	604
E. Vokes United States	9	167 0.9×	89 0.6×	168 1.5×	141 1.3×	198 2.0×	20	495
Antonio Cremades Spain	11	131 0.7×	142 0.9×	21 0.2×	76 0.7×	65 0.6×	24	384
Simonetta Kerim Italy	15	137 0.7×	46 0.3×	46 0.4×	77 0.7×	121 1.2×	34	521
U. Schumacher Germany	8	150 0.8×	228 1.5×	38 0.3×	293 2.7×	84 0.8×	12	587

Countries citing papers authored by P.Y. Dietrich

Since Specialization

Citations

This map shows the geographic impact of P.Y. Dietrich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P.Y. Dietrich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P.Y. Dietrich more than expected).

Fields of papers citing papers by P.Y. Dietrich

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P.Y. Dietrich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P.Y. Dietrich. The network helps show where P.Y. Dietrich may publish in the future.

Co-authorship network of co-authors of P.Y. Dietrich

This figure shows the co-authorship network connecting the top 25 collaborators of P.Y. Dietrich. A scholar is included among the top collaborators of P.Y. Dietrich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P.Y. Dietrich. P.Y. Dietrich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Bassoy, Esen Yonca, Atsuko Kasahara, Guillaume Jacquemin, et al.. (2017). ER –mitochondria contacts control surface glycan expression and sensitivity to killer lymphocytes in glioma stem‐like cells. The EMBO Journal. 36(11). 1493–1512. 26 indexed citations

Roosnek, Eddy, et al.. (2009). Tumors that look for their springtime in APRIL. Critical Reviews in Oncology/Hematology. 72(2). 91–97. 19 indexed citations

Martinelli, Giovanni, U Hess, Roger Stupp, et al.. (2009). 9206 Long-term follow-up of follicular lymphoma (FL) patients receiving single agent rituximab at two different schedules in trial SAKK 35/98. European Journal of Cancer Supplements. 7(2). 562–562. 1 indexed citations

Kerl, Katrin, et al.. (2008). Bortezomib-Induced Skin Eruption. Dermatology. 216(2). 156–158. 11 indexed citations

Staehler, Michael, P.Y. Dietrich, Timothy Eisen, et al.. (2007). A phase I study to evaluate safety, immunogenicity and anti-tumor activity of the multi-peptide vaccine IMA901 in renal cell carcinoma patients (RCC). Journal of Clinical Oncology. 25(18_suppl). 5098–5098. 5 indexed citations

Singh‐Jasuja, Harpreet, Steffen Walter, Aaron T. Mayer, et al.. (2007). Correlation of T-cell response, clinical activity and regulatory T-cell levels in renal cell carcinoma patients treated with IMA901, a novel multi-peptide vaccine. Journal of Clinical Oncology. 25(18_suppl). 3017–3017. 1 indexed citations

Cahana, Alex, et al.. (2005). Percutaneous Vertebroplasty in Octogenarians: Results and Follow‐Up. Pain Practice. 5(4). 316–323. 12 indexed citations

Meidenbauer, Norbert, Alfred Zippelius, Mikäel J. Pittet, et al.. (2004). High Frequency of Functionally Active Melan-A–Specific T Cells in a Patient with Progressive Immunoproteasome-Deficient Melanoma. Cancer Research. 64(17). 6319–6326. 48 indexed citations

Zouhair, Abderrahim, Damien C. Weber, Yazid Belkacémi, et al.. (2002). Outcome and patterns of failure in testicular lymphoma: a multicenter rare cancer network study. International Journal of Radiation Oncology*Biology*Physics. 52(3). 652–656. 40 indexed citations

10.

Conconi, Annarita, Catherine Thieblemont, Andrés J.M. Ferreri, et al.. (2002). Activity of Rituximab in Extranodal Marginal Zone Lymphomas (MALT Type). 7 indexed citations

11.

Castagna, Luca, E Benhamou, M. Luboinski, et al.. (2001). Prevention of mucositis in bone marrow transplantation: A double blind randomised controlled trial of sucralfate. Annals of Oncology. 12(7). 953–955. 30 indexed citations

12.

Laurencet, France M., et al.. (2000). Mental neuropathy: report of five cases and review of the literature. Critical Reviews in Oncology/Hematology. 34(1). 71–79. 69 indexed citations

13.

Hildebrand, Janet S., O. Dewitte, P.Y. Dietrich, & Nicolas de Tribolet. (1997). Management of Malignant Brain Tumors. European Neurology. 38(3). 238–253. 21 indexed citations

14.

Waanders, Gary A., Donata Rimoldi, D. Liénard, et al.. (1997). Melanoma-reactive human cytotoxic T lymphocytes derived from skin biopsies of delayed-type hypersensitivity reactions induced by injection of an autologous melanoma cell line.. PubMed. 3(5). 685–96. 17 indexed citations

15.

Caignard, Anne, P.Y. Dietrich, Apiradee Lim, et al.. (1994). Evidence for T-cell clonal expansion in a patient with squamous cell carcinoma of the head and neck.. PubMed. 54(5). 1292–7. 48 indexed citations

16.

Bodis, Stephan, M. Henry‐Amar, J. Bosq, et al.. (1993). Late relapse in early-stage Hodgkin's disease patients enrolled on European Organization for Research and Treatment of Cancer protocols.. Journal of Clinical Oncology. 11(2). 225–232. 42 indexed citations

17.

Dietrich, P.Y., et al.. (1993). Primary diffuse leptomeningeal gliomatosis (PDLG): A neoplastic cause of chronic meningitis. Journal of Neuro-Oncology. 15(3). 275–283. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact